Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
American Journal of Hematology
|
January 31, 2025
Dirt Under the Finger-Nails-More Malignant Than Malignancy
Sumeet Mirgh, Sujata Lall, Sachin Punatar, et al.
Blood Cell Therapy
|
December 26, 2023
Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant
Komal Kumbhalwar, Sachin Punatar, Anant Gokarn, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
June 26, 2023
Monocyte Distribution Width (MDW) in Patients with COVID-19: An Indicator of Disease Severity
Praveen Sharma, Shano Naseem, Neelam Varma, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 1, 2020
Carfilzomib-induced Thrombotic Microangiopathy: A Case Based Review
Nishant Jindal, Aditya Jandial, Arihant Jain, et al.
European Journal of Haematology
|
August 5, 2020
Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire
Padma Youron, Charanpreet Singh, Nishant Jindal, et al.
Blood Cell Therapy
|
June 9, 2025
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias
Sachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, et al.
Leukemia & Lymphoma
|
February 22, 2021
Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL
Nishant Jindal, Deepesh P Lad, Pankaj Malhotra, et al.
The Indian Journal of Medical Research
|
April 11, 2023
Feasibility of treatment-free remission with generic imatinib: Results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase study
Deepak Goni, Arihant Jain, Charanpreet Singh, et al.
International Journal of Hematology
|
November 12, 2023
Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Akanksha Chichra, Lingaraj Nayak, Rushabh Kothari, et al.
JCO Global Oncology
|
June 25, 2020
Chronic Lymphocytic Leukemia: Real-World Data From India
V Tejaswi, Deepesh P Lad, Nishant Jindal, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
American Journal of Hematology
|
January 31, 2025
Dirt Under the Finger-Nails-More Malignant Than Malignancy
Sumeet Mirgh, Sujata Lall, Sachin Punatar, et al.
Blood Cell Therapy
|
December 26, 2023
Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant
Komal Kumbhalwar, Sachin Punatar, Anant Gokarn, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
June 26, 2023
Monocyte Distribution Width (MDW) in Patients with COVID-19: An Indicator of Disease Severity
Praveen Sharma, Shano Naseem, Neelam Varma, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 1, 2020
Carfilzomib-induced Thrombotic Microangiopathy: A Case Based Review
Nishant Jindal, Aditya Jandial, Arihant Jain, et al.
European Journal of Haematology
|
August 5, 2020
Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire
Padma Youron, Charanpreet Singh, Nishant Jindal, et al.
Blood Cell Therapy
|
June 9, 2025
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias
Sachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, et al.
Leukemia & Lymphoma
|
February 22, 2021
Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL
Nishant Jindal, Deepesh P Lad, Pankaj Malhotra, et al.
The Indian Journal of Medical Research
|
April 11, 2023
Feasibility of treatment-free remission with generic imatinib: Results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase study
Deepak Goni, Arihant Jain, Charanpreet Singh, et al.
International Journal of Hematology
|
November 12, 2023
Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Akanksha Chichra, Lingaraj Nayak, Rushabh Kothari, et al.
JCO Global Oncology
|
June 25, 2020
Chronic Lymphocytic Leukemia: Real-World Data From India
V Tejaswi, Deepesh P Lad, Nishant Jindal, et al.
Page
of 4